2. Academic Validation
  3. Nitrofuran-Based STING Inhibitors

Nitrofuran-Based STING Inhibitors

  • ACS Omega. 2025 Sep 4;10(36):41693-41706. doi: 10.1021/acsomega.5c05578.
Leonard Barasa 1 2,  Leo DeOrsey 1 2,  Maeve D O'Reilly 1 2,  Shruti Choudhary 1 2,  Sara E Cahill 3,  Anukriti Mathur 3,  Sakshi Rajoria 1 2,  Robert Madison Green 1 2,  Akumalla Allabaji 4,  Shreekrishna Nellikkalaya 4,  Sourav Paul 4,  Srinivasa Rao Vidadala 4,  Sujit Kumar Sarkar 4,  Santoshkumar N Patil 4,  Jeffrey Hale 5,  Fiachra Humphries 3,  Katherine A Fitzgerald 3,  Paul R Thompson 1 2
Affiliations

Affiliations

  • 1 Program in Chemical Biology, University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
  • 2 Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
  • 3 Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, 364 Plantation Street, Worcester, Massachusetts 01605, United States.
  • 4 Syngene International Ltd., Bommasandra-Jigani Link Road, Biocon Park, Bangalore 560100, India.
  • 5 Jeffrey Hale, Hale MedChem Advisors LLC, 233 Hazel Ave, Westfield, New Jersey 07090, United States.
PMID: 40978405 DOI: 10.1021/acsomega.5c05578
Abstract

The cGAS-STING pathway plays a central role in the host response to foreign DNA. While cGAS-STING signaling is essential for Antiviral immunity, aberrant STING activation is observed in amyotrophic lateral sclerosis (ALS), lupus, and autoinflammatory diseases such as Aicardi-Goutières syndrome (AGS) and STING associated vasculopathy with onset in infancy (SAVI). Thus, STING inhibitors are likely therapeutic agents. BB-Cl-amidine and LB244 are recently reported STING antagonists that work by blocking STING oligomerization. Herein, we describe the diverse strategies taken to optimize the potency of LB244. These efforts led to the development of UM-242 and UM-259. UM-242 and UM-259 both inhibit mouse and human STING-dependent signaling with efficacy similar to that of LB244. We further show that UM-242 and UM-259 maintain their potency against the most common human STING variant (R232) and inhibit STING signaling in primary human CD14+ monocytes. In summary, UM-242 and UM-259 represent additional novel scaffolds for the development of therapeutics to treat STING-dependent inflammatory diseases.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z